Covered recipient · General Payments record
THOMAS J DUNCAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,321.91
- Reported across 185 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $457.44 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $144.61 | 9 |
| ABBVIE INC. | $139.20 | 7 |
| Amgen Inc. | $45.77 | 2 |
| Astellas Pharma US Inc | $28.66 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.54 | 1 |
| PFIZER INC. | $21.88 | 1 |
| Medtronic, Inc. | $21.09 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.51 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.81 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103666678 | CMS |
| ABBVIE INC. | $20.56 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103666680 | CMS |
| ABBVIE INC. | $23.83 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103666682 | CMS |
| ABBVIE INC. | $31.67 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103666684 | CMS |
| ABBVIE INC. | $7.08 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103666686 | CMS |
| ABBVIE INC. | $23.77 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103666688 | CMS |
| ABBVIE INC. | $19.48 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103666690 | CMS |
| Amgen Inc. | $29.09 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117545790 | CMS |
| Amgen Inc. | $16.68 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117545792 | CMS |
| Astellas Pharma US Inc | $28.66 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139407453 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.18 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086221065 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.54 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118088382 | CMS |
| Medtronic, Inc. | $21.09 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119410820 | CMS |
| Novartis Pharmaceuticals Corporation | $16.51 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086950803 | CMS |
| Novo Nordisk Inc | $8.41 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097144176 | CMS |
| Novo Nordisk Inc | $20.93 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096614560 | CMS |
| Novo Nordisk Inc | $10.30 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097569357 | CMS |
| Novo Nordisk Inc | $24.81 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096724983 | CMS |
| Novo Nordisk Inc | $14.74 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096938475 | CMS |
| Novo Nordisk Inc | $13.12 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096725905 | CMS |
| Novo Nordisk Inc | $15.05 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096918498 | CMS |
| Novo Nordisk Inc | $21.00 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096623108 | CMS |
| Novo Nordisk Inc | $16.25 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097750672 | CMS |
| PFIZER INC. | $21.88 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131128176 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.